Citation: | WU Jie, CHEN Xin, MAO Huifang, CHENG Jin, WEI Suo, WANG Lihua. Investigation of quality of life in Duchenne muscular dystrophy children in Anhui Province and analysis of influencing factors[J]. Chinese Journal of General Practice, 2025, 23(4): 613-617. doi: 10.16766/j.cnki.issn.1674-4152.003963 |
[1] |
CHANG M Y, CAI Y, GAO Z H, et al. Duchenne muscular dystrophy: pathogenesis and promising therapies[J]. J Neurol, 2023, 270(8): 3733-3749. doi: 10.1007/s00415-023-11796-x
|
[2] |
DUBININ M V, TALANOV E Y, TENKOV K S, et al. The effect of deflazacort treatment on the functioning of skeletal muscle mitochondria in Duchenne muscular dystrophy[J]. Int J Mol Sci, 2020, 21(22): 8763. DOI: 10.3390/ijms21228763.
|
[3] |
ZHANG Y, MANN J R, JAMES K A, et al. Duchenne and becker muscular dystrophies' prevalence in MD STARnet surveillance sites: an examination of racial and ethnic differences[J]. Neuroepidemiology, 2021, 55(1): 47-55. doi: 10.1159/000512647
|
[4] |
MARKATI T, OSKOUI M, FARRAR M A, et al. Emerging therapies for Duchenne muscular dystrophy[J]. Lancet Neurol, 2022, 21(9): 814-829. doi: 10.1016/S1474-4422(22)00125-9
|
[5] |
应筱雯, 唐根富, 舒霁, 等. SF-12和EQ-5D评价连云港市农村地区老年高血压患者生命质量的比较[J]. 中华全科医学, 2021, 19(4): 599-602. doi: 10.16766/j.cnki.issn.1674-4152.001871
YING X W, TANG G F, SHU J, et al. Comparison of SF-12 and EQ-5D evaluation of quality of life in elderly hypertensive patients in rural areas of Lianyungang City[J]. Chinese Journal of General Practice, 2021, 19(4): 599-602. doi: 10.16766/j.cnki.issn.1674-4152.001871
|
[6] |
BELLO T K, GERICKE G J, MACLNTYRE U E, et al. A nutrition education programme improves quality of life but not anthropometric status of adults living with HIV in Abeokuta, Nigeria[J]. Public Health Nutr, 2019, 22(12): 2290-2302. doi: 10.1017/S1368980019000636
|
[7] |
刘文静, 郭小铭, 玉纪满, 等. 孤独症谱系障碍儿童生存质量的研究[J]. 中国现代药物应用, 2019, 13(10): 26-28.
LIU W J, GUO X M, YU J M, et al. Study on quality of life of children with autism spectrum disorder[J]. Chinese Journal of Modern Drug Application, 2019, 13(10): 26-28.
|
[8] |
WEERKAMP P M M, GEUENS S, COLLIN P, et al. Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world data[J]. Neuromuscul Disord, 2023, 33(7): 619-626. doi: 10.1016/j.nmd.2023.05.011
|
[9] |
中华医学会医学遗传学分会遗传病临床实践指南撰写组. 杜氏进行性肌营养不良的临床实践指南[J]. 中华医学遗传学杂志, 2020, 37(3): 258-262.
Genetic Disease Clinical Practice Guideline writing Group, Chinese Medical Genetics Society. Clinical practice guidelines for Duchenne' s progressive muscular dystrophy[J]. Chinese Journal of Medical Genetics, 2020, 37(3): 258-262.
|
[10] |
卢奕云, 田琪, 郝元涛, 等. 儿童生存质量测定量表PedsQL 4.0中文版的信度和效度分析[J]. 中山大学学报(医学科学版), 2008(3): 328-331.
LU Y Y, TIAN Q, HAO Y T, et al. Reliability and validity analysis of the Chinese version of children, s quality of life measurement table PedsQL4.0[J]. Journal of Sun Yat-sen University(Medical Sciences), 2008(3): 328-331.
|
[11] |
COSTANTINI L, PASQUARELLA C, ODONE A, et al. Screening for depression in primary care with patient health questionnaire-9 (PHQ-9): a systematic review[J]. Affect Disord, 2021, 279: 473-483. doi: 10.1016/j.jad.2020.09.131
|
[12] |
ZHAO Y, AYUN R, OLDENBURG B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data[J]. Lancet Glob Health, 2020, 8(6): e840-e849. doi: 10.1016/S2214-109X(20)30127-3
|
[13] |
UZARK K, KING E, CRIPE L, et al. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy[J]. Pediatrics, 2012, 130(6): e1559-e1566. doi: 10.1542/peds.2012-0858
|
[14] |
LIANG R, CHAN S H S, HO F K W, et al. Health-related quality of life in Chinese boys with Duchenne muscular dystrophy and their families[J]. J Child Health Care, 2019, 23(3): 495-506. doi: 10.1177/1367493519857423
|
[15] |
GUGLIERI M, BUSHBY K, MCDERMOTT M P, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial[J]. JAMA, 2022, 327(15): 1456-1468. doi: 10.1001/jama.2022.4315
|
[16] |
李西华, 赵蕾, 胡超平, 等. 复旦大学附属儿科医院Duchenne型和Becker型肌营养不良症数据库的建立[J]. 中国现代神经疾病杂志, 2015, 15(5): 360-368.
LI X H, ZHAO L, HU C P, et al. Establishment of Duchenne muscular dystrophy and Bayes muscular dystrophy database in Children' s Hospital of Fudan University[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2015, 15(5): 360-368.
|
[17] |
马燕燕, 岳雪艳, 茹凉, 等. 糖皮质激素联合综合康复疗法对Duchenne型肌营养不良患儿认知功能及炎性反应水平的影响[J]. 疑难病杂志, 2021, 20(3): 274-277, 282.
MA Y Y, YUE X Y, RU L, et al. The effect of glucocorticoids combined with comprehensive rehabilitation therapy on cognitive function and inflammatory response levels in children with Duchenne muscular dystrophy[J]. Chinese Journal of Difficult and Complicated Cases, 2021, 20(3): 274-277, 282.
|
[18] |
ARAUJO A P Q C, SAUTE J A M, FORTES C P D D, et al. Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy[J]. Arq Neuro-psiquiat, 2023, 81(1): 81-94.
|
[19] |
ORSO M, MIGLIORE A, POLISTENA B, et al. Duchenne muscular dystrophy in Italy: a systematic review of epidemiology, quality of life, treatment adherence, and economic impact[J]. PLoS One, 2023, 18(6): e0287774. DOI: 10.1371/journal.pone.0287774.
|
[20] |
LEMMON M E, GLASS H C, SHELLHAAS R A, et al. Family-centered care for children and families impacted by neonatal seizures: advice from parents[J]. Pediatr Neurol, 2021, 124: 26-32.
|
[21] |
刘小燕, 冯雪英, 衣明纪, 等. 儿童抑郁症状及其行为与家庭因素的相关性[J]. 中国学校卫生, 2019, 40(12): 1849-1851, 1854.
LIU X Y, FENG X Y, YI M J, et al. Correlation of depressive symptoms and behaviors in children with family factors[J]. Chin J Sch Health, 2019, 40(12): 1849-1851, 1854.
|